Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association of IL-13 in respiratory syncytial virus-induced pulmonary disease: still a promising target.

× No keyword cloud information.

52 in total

1. Respiratory syncytial virus predisposes mice to augmented allergic airway responses via IL-13-mediated mechanisms.

Authors: N W Lukacs; K K Tekkanat; A Berlin; C M Hogaboam; A Miller; H Evanoff; P Lincoln; H Maassab
Journal: J Immunol Date: 2001-07-15 Impact factor: 5.422

Review 2. Mechanisms of virus induced exacerbations of asthma.

Authors: J M Corne; S T Holgate
Journal: Thorax Date: 1997-04 Impact factor: 9.139

Review 3. Respiratory syncytial virus and other respiratory viruses.

Authors: Robert C Welliver
Journal: Pediatr Infect Dis J Date: 2003-02 Impact factor: 2.129

Review 4. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches.

Authors: Peter J Openshaw; Gillian S Dean; Fiona J Culley
Journal: Pediatr Infect Dis J Date: 2003-02 Impact factor: 2.129

5. IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge.

Authors: Teresa R Johnson; Robert A Parker; Joyce E Johnson; Barney S Graham
Journal: J Immunol Date: 2003-02-15 Impact factor: 5.422

6. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.

Authors: Timothy F Feltes; Allison K Cabalka; H Cody Meissner; Franco M Piazza; David A Carlin; Franklin H Top; Edward M Connor; Henry M Sondheimer
Journal: J Pediatr Date: 2003-10 Impact factor: 4.406

7. Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine.

Authors: V A Fulginiti; J J Eller; O F Sieber; J W Joyner; M Minamitani; G Meiklejohn
Journal: Am J Epidemiol Date: 1969-04 Impact factor: 4.897

8. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.

Authors: G Rohde; A Wiethege; I Borg; M Kauth; T T Bauer; A Gillissen; A Bufe; G Schultze-Werninghaus
Journal: Thorax Date: 2003-01 Impact factor: 9.139

9. Mortality associated with influenza and respiratory syncytial virus in the United States.

Authors: William W Thompson; David K Shay; Eric Weintraub; Lynnette Brammer; Nancy Cox; Larry J Anderson; Keiji Fukuda
Journal: JAMA Date: 2003-01-08 Impact factor: 56.272

Review 10. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection.

Authors: Robert C Welliver
Journal: J Pediatr Date: 2003-11 Impact factor: 4.406

4 in total

1. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.

Authors: Fabián E Díaz; Mariana Guerra-Maupome; Paiton O McDonald; Daniela Rivera-Pérez; Alexis M Kalergis; Jodi L McGill
Journal: Front Immunol Date: 2021-04-26 Impact factor: 7.561

2. Roflumilast inhibits respiratory syncytial virus infection in human differentiated bronchial epithelial cells.

Authors: Manuel Mata; Isidoro Martinez; Jose A Melero; Herman Tenor; Julio Cortijo
Journal: PLoS One Date: 2013-07-23 Impact factor: 3.240

3. Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica.

Authors: Jodi L McGill; Rachel A Rusk; Mariana Guerra-Maupome; Robert E Briggs; Randy E Sacco
Journal: PLoS One Date: 2016-03-04 Impact factor: 3.240

Review 4. Innate Type 2 Responses to Respiratory Syncytial Virus Infection.

Authors: Allison E Norlander; R Stokes Peebles
Journal: Viruses Date: 2020-05-08 Impact factor: 5.048

4 in total